Copyright Reports & Markets. All rights reserved.

Global Actinic Keratosis Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Actinic Keratosis Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Destructive Treatment
      • 1.4.3 Photodynamic Therapy
      • 1.4.4 Topical Medications
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Actinic Keratosis Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Actinic Keratosis Treatment Market Size
    • 2.2 Actinic Keratosis Treatment Growth Trends by Regions
      • 2.2.1 Actinic Keratosis Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Actinic Keratosis Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Actinic Keratosis Treatment Market Size by Manufacturers
      • 3.1.1 Global Actinic Keratosis Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Actinic Keratosis Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Actinic Keratosis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Actinic Keratosis Treatment Key Players Head office and Area Served
    • 3.3 Key Players Actinic Keratosis Treatment Product/Solution/Service
    • 3.4 Date of Enter into Actinic Keratosis Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Actinic Keratosis Treatment Market Size by Type (2014-2019)
    • 4.2 Global Actinic Keratosis Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Actinic Keratosis Treatment Market Size (2014-2019)
    • 5.2 Actinic Keratosis Treatment Key Players in United States
    • 5.3 United States Actinic Keratosis Treatment Market Size by Type
    • 5.4 United States Actinic Keratosis Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Actinic Keratosis Treatment Market Size (2014-2019)
    • 6.2 Actinic Keratosis Treatment Key Players in Europe
    • 6.3 Europe Actinic Keratosis Treatment Market Size by Type
    • 6.4 Europe Actinic Keratosis Treatment Market Size by Application

    7 China

    • 7.1 China Actinic Keratosis Treatment Market Size (2014-2019)
    • 7.2 Actinic Keratosis Treatment Key Players in China
    • 7.3 China Actinic Keratosis Treatment Market Size by Type
    • 7.4 China Actinic Keratosis Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Actinic Keratosis Treatment Market Size (2014-2019)
    • 8.2 Actinic Keratosis Treatment Key Players in Japan
    • 8.3 Japan Actinic Keratosis Treatment Market Size by Type
    • 8.4 Japan Actinic Keratosis Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Actinic Keratosis Treatment Market Size (2014-2019)
    • 9.2 Actinic Keratosis Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Actinic Keratosis Treatment Market Size by Type
    • 9.4 Southeast Asia Actinic Keratosis Treatment Market Size by Application

    10 India

    • 10.1 India Actinic Keratosis Treatment Market Size (2014-2019)
    • 10.2 Actinic Keratosis Treatment Key Players in India
    • 10.3 India Actinic Keratosis Treatment Market Size by Type
    • 10.4 India Actinic Keratosis Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Actinic Keratosis Treatment Market Size (2014-2019)
    • 11.2 Actinic Keratosis Treatment Key Players in Central & South America
    • 11.3 Central & South America Actinic Keratosis Treatment Market Size by Type
    • 11.4 Central & South America Actinic Keratosis Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 DUSA Pharmaceuticals
      • 12.1.1 DUSA Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Actinic Keratosis Treatment Introduction
      • 12.1.4 DUSA Pharmaceuticals Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.1.5 DUSA Pharmaceuticals Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Actinic Keratosis Treatment Introduction
      • 12.2.4 Novartis Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Perrigo
      • 12.3.1 Perrigo Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Actinic Keratosis Treatment Introduction
      • 12.3.4 Perrigo Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.3.5 Perrigo Recent Development
    • 12.4 LEO Pharma
      • 12.4.1 LEO Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Actinic Keratosis Treatment Introduction
      • 12.4.4 LEO Pharma Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.4.5 LEO Pharma Recent Development
    • 12.5 Bausch Health
      • 12.5.1 Bausch Health Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Actinic Keratosis Treatment Introduction
      • 12.5.4 Bausch Health Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.5.5 Bausch Health Recent Development
    • 12.6 Taro Pharmaceutical
      • 12.6.1 Taro Pharmaceutical Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Actinic Keratosis Treatment Introduction
      • 12.6.4 Taro Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.6.5 Taro Pharmaceutical Recent Development
    • 12.7 Galderma (Nestle)
      • 12.7.1 Galderma (Nestle) Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Actinic Keratosis Treatment Introduction
      • 12.7.4 Galderma (Nestle) Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.7.5 Galderma (Nestle) Recent Development
    • 12.8 Biofrontera
      • 12.8.1 Biofrontera Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Actinic Keratosis Treatment Introduction
      • 12.8.4 Biofrontera Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.8.5 Biofrontera Recent Development
    • 12.9 Almirall
      • 12.9.1 Almirall Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Actinic Keratosis Treatment Introduction
      • 12.9.4 Almirall Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.9.5 Almirall Recent Development
    • 12.10 Tolmar Pharmaceutical
      • 12.10.1 Tolmar Pharmaceutical Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Actinic Keratosis Treatment Introduction
      • 12.10.4 Tolmar Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2014-2019)
      • 12.10.5 Tolmar Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
      The classification of Actinic Keratosis Treatment includes Destructive Treatment, Photodynamic Therapy, Topical Medications and Other, and the Most of Actinic Keratosis Treatment is Destructive Treatment, and proportion of Destructive Treatment in 2017 is about 81.4%. Cryotherapy was the most ordinarily looked for treatment by clinicians. Notwithstanding, better clinical consequences of photodynamic treatment and developing inclination for medications in view of medication gadget mix have asked both parental figures and patients to choose novel treatment techniques that offer both propelled adequacy, stylish advantages and decreased danger of future malignancies.
      Actinic Keratosis Treatment is widely used in hospital, clinic and other. The most proportion of Actinic Keratosis Treatment is used in clinic, and the proportion in 2017 is about 63%.
      Market competition is intense. DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The major company of Photodynamic Therapy for Actinic Keratosis Treatment is DUSA Pharmaceuticals, Galderma (Nestle), Biofrontera in USA.
      In 2018, the global Actinic Keratosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Actinic Keratosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Actinic Keratosis Treatment development in United States, Europe and China.

      The key players covered in this study
      DUSA Pharmaceuticals
      Novartis
      Perrigo
      LEO Pharma
      Bausch Health
      Taro Pharmaceutical
      Galderma (Nestle)
      Biofrontera
      Almirall
      Tolmar Pharmaceutical

      Market segment by Type, the product can be split into
      Destructive Treatment
      Photodynamic Therapy
      Topical Medications
      Other

      Market segment by Application, split into
      Hospital
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Actinic Keratosis Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Actinic Keratosis Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Actinic Keratosis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now